The Big Development In offices from New York to Nairobi, a curious pattern is emerging: professionals are doing more work in ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

DLocal Limited (NASDAQ:DLO) Q4 2025 Earnings Call Transcript March 18, 2026 DLocal Limited beats earnings expectations. Reported EPS is $0.22, expectations were $0.1791. Operator: Good day. Thank you ...

In patients who had progressed on one prior ARPI, FG3246 plus enzalutamide yielded a median radiographic progression-free survival (rPFS) of 10.1 months and PSA50 response of 40%. Phase I Monotherapy ...

How close are we to the sci-fi vision of autonomous humanoid robots? I visited 11 companies in five Chinese cities to find out ...

As a reminder, today's earnings release, presentation, and statements made during this call include forward-looking statements under federal securities laws. Initial price is always important, but ...

Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...

Gabelli Funds Annual Specialty Chemicals Symposium March 19, 2026 1:30 PM EDTCompany ParticipantsWilliam Whitaker - Senior VP, CFO ...

The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...

AI is rapidly reshaping the landscape of surgical oncology. However, its true potential lies not in isolated tools, but rather ...

Brian Humbarger, our new Chief Commercial Officer, will provide an overview of our limited commercial launch. Before we dive into updates since our last call in November, I want to remind everyone ...